PRT-811

N/A

Report date: 2024/08/26 10:52:57
NME

Base Information

Drug NamePRT-811
Drug Alias NamePRT-811P-500
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein arginine methyltransferase 5 inhibitors
TargetsProtein arginine methyltransferase 5
Therapy Area/IndicationsSolid tumoursGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPrelude Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesPathos AI IncPrelude Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursGlioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A